It is a life-altering issue affecting half of all men between 51 and 60, and it only worsens with age. Benign prostatic hyperplasia, also known as BPH or benign enlarged prostate, is among the most common urological diagnoses in men, according to the American Urological Association.
“Men can begin experiencing symptoms as early as their mid-30s, but typical cases occur in men who are in their 50s and 60s,” said Joseph Costa, DO, a UF Health urologist.
The prostate is located between the bladder and urethra, the tube men use to urinate. As the prostate grows, it can squeeze down on the urethra, causing symptoms that greatly impact quality of life.
“Patients can experience frequent urination, restlessness due to multiple nighttime trips to the bathroom, pushing or straining to urinate, weak urinary stream, trouble emptying their bladder and sexual dysfunction,” Costa said. “If left untreated, BPH can cause urinary tract infections and in extreme cases can lead to permanent bladder or kidney damage.”
UroLift is a Food and Drug Administration-approved, minimally invasive outpatient procedure that uses tiny implants to relieve obstruction by the prostate without cutting, heating or removal of tissues, as with prior treatments. The procedure can be done in minutes, and afterward, men are able to walk out the door.